{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:23:48Z","timestamp":1707524628018},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,14]]},"DOI":"10.7759\/cureus.27998","type":"journal-article","created":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T16:12:08Z","timestamp":1660493528000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical Characteristics and Outcome Related to Blood Eosinophilic Chronic Obstructive Pulmonary Disease (COPD) Patients"],"prefix":"10.7759","author":[{"given":"Amr","family":"Albanna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatimah M","family":"Almuyidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noura F","family":"Beitar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal S","family":"Alshumrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyad F","family":"Al Nufaiei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rouzana","family":"Khayat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Althaqafy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hawazen I","family":"Abdulmannan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1183\/20734735.0346-2018","article-title":"Under- and over-diagnosis of COPD: a global perspective","volume":"15","author":"Ho T","year":"2019","unstructured":"Ho T, Cusack RP, Chaudhary N, Satia I, Kurmi OP. Under- and over-diagnosis of COPD: a global perspective. Breathe (Sheff). 2019, 15:24-35. 10.1183\/20734735.0346-2018","journal-title":"Breathe (Sheff)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158843","article-title":"A systematic review of diagnostic biomarkers of copd exacerbation","volume":"11","author":"Chen YW","year":"2016","unstructured":"Chen YW, Leung JM, Sin DD. A systematic review of diagnostic biomarkers of copd exacerbation. PLoS One. 2016, 11:e0158843. 10.1371\/journal.pone.0158843","journal-title":"PLoS One"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8070962","article-title":"Reassessing the role of eosinophils as a biomarker in chronic obstructive pulmonary disease","volume":"8","author":"Tin\u00e8 M","year":"2019","unstructured":"Tin\u00e8 M, Biondini D, Semenzato U, Bazzan E, Cosio MG, Saetta M, Turato G. Reassessing the role of eosinophils as a biomarker in chronic obstructive pulmonary disease. J Clin Med. 2019, 8:10.3390\/jcm8070962","journal-title":"J Clin Med"},{"key":"ref4","unstructured":"GOLD. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. (2019). Accessed. Accessed: March 3, 2020: Available from: http:\/\/goldcopd.org: http:\/\/goldcopd.org\/."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1183\/20734735.0254-2019","article-title":"COPD treatment choices based on blood eosinophils: are we there yet?","volume":"15","author":"Oliver B","year":"2019","unstructured":"Oliver B, Tonga K, Darley D, Rutting S, Zhang X, Chen H, Wang G. COPD treatment choices based on blood eosinophils: are we there yet?. Breathe (Sheff). 2019, 15:318-23. 10.1183\/20734735.0254-2019","journal-title":"Breathe (Sheff)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00162414","article-title":"Eosinophilic inflammation in COPD: prevalence and clinical characteristics","volume":"44","author":"Singh D","year":"2014","unstructured":"Singh D, Kolsum U, Brightling CE, Locantore N, Agusti A, Tal-Singer R. Eosinophilic inflammation in COPD: prevalence and clinical characteristics. Eur Respir J. 2014, 44:1697-700. 10.1183\/09031936.00162414","journal-title":"Eur Respir J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-019-1268-7","article-title":"Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis","volume":"21","author":"Harries TH","year":"2020","unstructured":"Harries TH, Rowland V, Corrigan CJ, et al.. Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis. Respir Res. 2020, 21:3. 10.1186\/s12931-019-1268-7","journal-title":"Respir Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00761-2017","article-title":"Blood eosinophil count and exacerbation risk in patients with COPD","volume":"50","author":"Kerkhof M","year":"2017","unstructured":"Kerkhof M, Sonnappa S, Postma DS, et al.. Blood eosinophil count and exacerbation risk in patients with COPD. Eur Respir J. 2017, 50:10.1183\/13993003.00761-2017","journal-title":"Eur Respir J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201108-1553OC","article-title":"Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial","volume":"186","author":"Bafadhel M","year":"2012","unstructured":"Bafadhel M, McKenna S, Terry S, et al.. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Am J Respir Crit Care Med. 2012, 186:48-55. 10.1164\/rccm.201108-1553OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(15)00106-X","article-title":"Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials","volume":"3","author":"Pascoe S","year":"2015","unstructured":"Pascoe S, Locantore N, Dransfield MT, et al.. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. Lancet Respir Med. 2015, 3:435-42. 10.1016\/S2213-2600(15)00106-X","journal-title":"Lancet Respir Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(16)00100-4","article-title":"Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial","volume":"4","author":"Watz H","year":"2016","unstructured":"Watz H, Tetzlaff K, Wouters EF, et al.. Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial. Lancet Respir Med. 2016, 4:390-8. 10.1016\/S2213-2600(16)00100-4","journal-title":"Lancet Respir Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2017.10.004","article-title":"Relationship of blood eosinophil count to exacerbations in chronic obstructive pulmonary disease","volume":"6","author":"Zeiger RS","year":"2018","unstructured":"Zeiger RS, Tran TN, Butler RK, et al.. Relationship of blood eosinophil count to exacerbations in chronic obstructive pulmonary disease. J Allergy Clin Immunol Pract. 2018, 6:944-954.e5. 10.1016\/j.jaip.2017.10.004","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.arbres.2019.12.015","article-title":"Blood eosinophil counts and their variability and risk of exacerbations in COPD: a population-based study","volume":"57","author":"Miravitlles M","year":"2021","unstructured":"Miravitlles M, Monteagudo M, Solntseva I, Alc\u00e1zar B. Blood eosinophil counts and their variability and risk of exacerbations in COPD: a population-based study. Arch Bronconeumol (Engl Ed). 2021, 57:13-20. 10.1016\/j.arbres.2019.12.015","journal-title":"Arch Bronconeumol (Engl Ed)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01659-2015","article-title":"Blood eosinophil count to predict bronchial eosinophilic inflammation in COPD","volume":"47","author":"Schleich F","year":"2016","unstructured":"Schleich F, Corhay JL, Louis R. Blood eosinophil count to predict bronchial eosinophilic inflammation in COPD. Eur Respir J. 2016, 47:1562-4. 10.1183\/13993003.01659-2015","journal-title":"Eur Respir J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201502-0235LE","article-title":"Blood eosinophils: a biomarker of response to extrafine beclomethasone\/formoterol in chronic obstructive pulmonary disease","volume":"192","author":"Siddiqui SH","year":"2015","unstructured":"Siddiqui SH, Guasconi A, Vestbo J, et al.. Blood eosinophils: a biomarker of response to extrafine beclomethasone\/formoterol in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015, 192:523-5. 10.1164\/rccm.201502-0235LE","journal-title":"Am J Respir Crit Care Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.04.010","article-title":"Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease","volume":"141","author":"Yun JH","year":"2018","unstructured":"Yun JH, Lamb A, Chase R, et al.. Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2018, 141:2037-2047.e10. 10.1016\/j.jaci.2018.04.010","journal-title":"J Allergy Clin Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/106038-clinical-characteristics-and-outcome-related-to-blood-eosinophilic-chronic-obstructive-pulmonary-disease-copd-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:47:44Z","timestamp":1707508064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/106038-clinical-characteristics-and-outcome-related-to-blood-eosinophilic-chronic-obstructive-pulmonary-disease-copd-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,14]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.27998","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,14]]}}}